Advertisement
Home Tags Cancer: Lung

Tag: Cancer: Lung

An integrated plasma proteomics classifier

Integrated Classifier Identifies Benign Lung Nodules

0
Classifier integrates relative abundance of two plasma proteins with clinical risk prediction model
The quality of shared decision-making about the initiation of lung cancer screening is poor

Poor Shared Decision-Making for Lung Cancer Screening

0
Physicians universally recommended screening, with almost no discussion of harms
Broad-based genomic sequencing does not improve survival compared to routine genetic testing among patients with advanced non-small-cell lung cancer

Broad Genetic Testing for NSCLC May Not Improve Survival

0
Compared with routine genetic testing, no improvement seen in unadjusted mortality rate
Biomarker-based risk profiling has the potential to improve lung cancer risk assessment

Biomarker Panel May Improve Lung Cancer Risk Assessment

0
Risk score based on panel of four circulating protein biomarkers
A radiomic low-dose computed tomography-based approach is promising for indeterminate screen-detected nodule characterization

Radiomic Model Approach for Characterizing Nodules Promising

0
Eight quantitative radiologic features result in optimism-corrected area under curve of 0.939
Awake video-assisted thoracoscopic surgery is a safe and feasible technique for patients with poor lung function and lung cancer

Awake VATS Can Be Safe Option for Some Lung Cancer Patients

0
Awake video-assisted thoracoscopic surgery safe, feasible for patients with poor lung function
Patients with advanced lung cancer have increased incidence of suicide

Palliative Care Reduces Odds of Suicide in Lung Cancer Patients

0
Only 20 percent of patients who died by suicide had a palliative care encounter
Three assays may detect early lung cancer in blood samples using genome sequencing

ASCO: New Assays May Detect Early Lung Cancer in Blood

0
Targeted sequencing, whole-genome sequencing, whole-genome bisulfite sequencing show potential
For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer

ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC

0
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
Personalizing the harm-benefit assessment of low-dose computed tomography screening for lung cancer can inform patient-centered screening decisions

Prediction Tool Helps Tailor Lung Cancer Screening to Patients

0
Researchers create web-based decision tool to facilitate personalized discussions